About: Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on January 2010

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2010 (ast) наукова стаття, опублікована в січні 2010 (uk) scientific article published on January 2010 (en) مقالة علمية نشرت في يناير 2010 (ar)
publication date	wds:Q37480893-64E4DDBF-E820-4650-9D96-4E2078AE6024
publication date	2010-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37480893-D2DA90F0-BABE-4E58-8BC5-7F05F5F57F0B
language of work or name	English
cites work	wds:Q37480893-01BB0AD0-B8A8-49C3-9EA0-3DFB3070949E wds:Q37480893-22760934-E804-4315-A414-FB06B72C025A wds:Q37480893-294D6A5C-0FE2-47C5-BD5D-909754B3CD3E wds:Q37480893-373732E2-6C4A-47AD-B468-C169E8F44FB6 wds:Q37480893-39D466D8-734B-4B92-98E1-D74D14CF6B58 wds:Q37480893-46D9A3F0-79B5-49AD-A8F3-A15346D3D2D6 wds:Q37480893-8E8A597B-7157-49DD-8FDA-EC84C82A3C4D wds:Q37480893-929E3A5D-B2D7-4607-A017-046ACA0A6551 wds:Q37480893-954C49FB-EE9C-4773-9533-232BB3620E87 wds:Q37480893-BBEDB8CB-D87F-487F-B1EB-E7E9CF808EEA wds:Q37480893-CEBC85AD-25B8-4F45-8C54-EE293880BDA4 wds:Q37480893-D21D729B-098E-4703-B138-D11306483BB3 wds:Q37480893-D501C75A-D1C4-4120-B466-D5D973019812 wds:Q37480893-EA446B73-1720-489D-9A6B-CF094A03274A wds:Q37480893-EF9BCB78-3E27-4DE6-8A11-360BA0011817 wds:Q37480893-F5828F9B-FF32-491E-9740-74FFC88FED59 wds:Q37480893-FB7C93CE-F98E-4262-AC51-B7EC319EEFE2
cites work	Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. Is alpha/beta for prostate tumors really low? Fractionation and protraction for radiotherapy of prostate carcinoma Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V
author name string	wds:Q37480893-0DD85B79-584A-4A80-BAF6-536EAE4BF9DD wds:Q37480893-178D12A6-8CF9-40AA-8DEC-B8E02A7A7C81 wds:Q37480893-36281122-5992-4838-B612-04510C9FEC56 wds:Q37480893-63F68593-EDC4-4A36-8643-A5926BB36B08 wds:Q37480893-80564541-8115-4D73-BB54-BB0C72DA5D19 wds:Q37480893-83CB292B-00B2-41C9-9468-46D23C6B0CDE wds:Q37480893-84EB0B43-0ABC-448F-A166-0CE29EA8A2C3 wds:Q37480893-C13767F6-A0E1-49B7-8E20-7577D79A4F6F wds:Q37480893-EE46B928-2BC3-48FB-9636-87F5B3CA51EB
author name string	Howard M Sandler Kyounghwa Bae Jeff M Michalski James D Cox Richard K Valicenti William Straube Arnold M Markoe Janice Ryu Matthew B Parliament
rdfs:label	Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (en) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (nl) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (ast)
skos:prefLabel	Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (en) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (nl) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (ast)
name	Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (en) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (nl) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (ast)
author	wds:Q37480893-115B69BA-269F-44BE-A9F7-4589C33F6FD4
author	Mack Roach
title	wds:Q37480893-F426FE05-D6CA-4ED5-8C60-5C9A263B397B
title	Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study (en)
page(s)	wds:Q37480893-C76A0C91-8EA6-46B0-90D7-CFF269EDD7FC
page(s)	14-22
instance of	wds:Q37480893-72DBDB68-D4F9-41A7-A742-52B4B61B6DED
instance of	scholarly article
main subject	wds:Q37480893-1A32D24E-5A0C-4B05-8023-C083BF7C0A14 wds:Q37480893-73CC4FD3-BACB-4CD8-A782-92E22AA62F12 wds:Q37480893-D62739C8-84A6-4EE4-AD23-B3008F4DA62B
main subject	prostate cancer toxicity radiation therapy
PubMed ID	wds:Q37480893-8EA7529D-3731-45B8-8C52-29955442751A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19577865
PubMed ID	19577865
published in	wds:Q37480893-5B5E2441-679A-460B-BFAE-9FE13E4B9079

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software